Literature DB >> 24875408

Factors affecting nasal intermittent positive pressure ventilation failure and impact on bronchopulmonary dysplasia in neonates.

P Mehta1, J Berger1, E Bucholz1, V Bhandari1.   

Abstract

BACKGROUND: Nasal intermittent positive pressure ventilation (NIPPV) is becoming more important as a mode of ventilation in premature neonates predisposed to development of bronchopulmonary dysplasia (BPD). To the best of our knowledge, there have been no detailed studies characterizing neonates who fail NIPPV.
OBJECTIVE: To determine the differences between neonates who are successfully extubated to NIPPV and those who require re-intubation from NIPPV, and the impact of timing of NIPPV failure on BPD rates. STUDY
DESIGN: This was a retrospective cohort study in which we included infants with gestational age (GA) ⩽ 28 weeks and birth weight ⩽ 1000 g. χ²-test, analysis of variance and multivariate logistic regression models were used.
RESULTS: Two hundred and forty infants were studied; 180 failed NIPPV and of those, 33 (18%), 39 (22%) and 108 (60%) failed NIPPV within 0 to 6 h, ⩾ 6 to 24 h and ⩾ 24 h, respectively. Female sex and increased weight were protective against NIPPV failure (adjusted odds ratio (95% confidence interval): 0.28 (0.14 to 0.58), 0.04 (0.01 to 0.22)). Increased GA at extubation and female sex were both associated with increased time to failure (P=0.008, <0.001, respectively). Apnea was more likely the cause for failure ⩾ 24 h (P=0.015), whereas increased work of breathing/fraction of inspired oxygen requirements were more significant when NIPPV failure occurred earlier (P=0.001). Neonates who failed NIPPV within 24 h did not have any association with likelihood of developing BPD or severity of BPD, after adjusting for confounding variables.
CONCLUSION: Significant differences in neonatal characteristics may help identify which neonates are more likely to fail NIPPV, and their timing of failure.

Entities:  

Mesh:

Year:  2014        PMID: 24875408     DOI: 10.1038/jp.2014.100

Source DB:  PubMed          Journal:  J Perinatol        ISSN: 0743-8346            Impact factor:   2.521


  42 in total

1.  Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes.

Authors: 
Journal:  Pediatrics       Date:  2000-02       Impact factor: 7.124

2.  The EPIBEL study: outcomes to discharge from hospital for extremely preterm infants in Belgium.

Authors:  Piet Vanhaesebrouck; Karel Allegaert; Jean Bottu; Christian Debauche; Hugo Devlieger; Martine Docx; Anne François; Dominique Haumont; Jacques Lombet; Jacques Rigo; Koenraad Smets; Inge Vanherreweghe; Bart Van Overmeire; Patrick Van Reempts
Journal:  Pediatrics       Date:  2004-09       Impact factor: 7.124

3.  Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia.

Authors:  K Cherukupalli; J E Larson; A Rotschild; W M Thurlbeck
Journal:  Pediatr Pulmonol       Date:  1996-10

Review 4.  Ventilatory management and bronchopulmonary dysplasia in preterm infants.

Authors:  Samir Gupta; Sunil K Sinha; Steven M Donn
Journal:  Semin Fetal Neonatal Med       Date:  2009-09-17       Impact factor: 3.926

Review 5.  Nasal intermittent positive pressure ventilation in the newborn: review of literature and evidence-based guidelines.

Authors:  V Bhandari
Journal:  J Perinatol       Date:  2009-10-22       Impact factor: 2.521

6.  Levels of neonatal care.

Authors: 
Journal:  Pediatrics       Date:  2012-08-27       Impact factor: 7.124

Review 7.  The potential of non-invasive ventilation to decrease BPD.

Authors:  Vineet Bhandari
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

8.  Hyperoxia-derived lung damage in preterm infants.

Authors:  Vineet Bhandari
Journal:  Semin Fetal Neonatal Med       Date:  2010-04-28       Impact factor: 3.926

9.  Bronchopulmonary dysplasia - prevalence, severity and predictive factors in a national cohort of extremely premature infants.

Authors:  T Farstad; D Bratlid; S Medbø; T Markestad
Journal:  Acta Paediatr       Date:  2011-01       Impact factor: 2.299

Review 10.  Sex and gender differences in lung development and their clinical significance.

Authors:  Hendrika M Boezen; Désirée F Jansen; Dirkje S Postma
Journal:  Clin Chest Med       Date:  2004-06       Impact factor: 2.878

View more
  5 in total

1.  The influence of gender on respiratory outcomes in children with bronchopulmonary dysplasia during the first 3 years of life.

Authors:  Joseph M Collaco; Angela D Aherrera; Sharon A McGrath-Morrow
Journal:  Pediatr Pulmonol       Date:  2016-06-30

Review 2.  Should we still use vitamin A to prevent bronchopulmonary dysplasia?

Authors:  X I Couroucli; J L Placencia; L A Cates; G K Suresh
Journal:  J Perinatol       Date:  2016-05-26       Impact factor: 2.521

Review 3.  Non-invasive Respiratory Support of the Premature Neonate: From Physics to Bench to Practice.

Authors:  Ibrahim Sammour; Sreenivas Karnati
Journal:  Front Pediatr       Date:  2020-05-08       Impact factor: 3.418

Review 4.  Understanding the Impact of Infection, Inflammation, and Their Persistence in the Pathogenesis of Bronchopulmonary Dysplasia.

Authors:  Jherna Balany; Vineet Bhandari
Journal:  Front Med (Lausanne)       Date:  2015-12-21

5.  Can biomarkers be used to predict bronchopulmonary dysplasia?

Authors:  Vineet Bhandari; Mitali Sahni
Journal:  J Pediatr (Rio J)       Date:  2020-10-23       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.